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Stroke-induced inflammatory reaction, which leads to invasion of leukocytes
into the evolving brain infarct, seems to play a key role in the deterioration of
brain ischaemic impairment. We have studied CSF and serum levels of tumour
necrosis factor-alpha (TNF-alpha), the potent proinflammatory cytokine, and pe-
ripheral white blood cells (WBC) counts in patients within the first 24 hours of
ischaemic stroke. TNF-alpha levels in CSF and serum as well as WBC counts were
increased. There was no correlation between TNF-alpha levels either in CSF and
serum or in WBC counts. The results of our study suggest that increased CSF
TNF-alpha levels may represent acute intracerebral inflammation in stroke, where-
as elevated levels of TNF-alpha in serum may reflect the peripheral proinflamma-
tory state as well as stroke-induced systemic inflammatory reaction. Increased
CSF and serum TNF-alpha levels do not correlate with the elevation of WBC
counts, suggesting that TNF-alpha overexpression observed in early phase of
stroke is not dependent on increased total number of peripheral leukocytes.
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INTRODUCTION
Accumulated data strongly suggest that cerebral is-
chaemia induces an inflammatory reaction leading
to secondary neuronal damage. This reaction is piv-
otally initiated by local intracerebral expression of
proinflammatory cytokines, including tumour necro-
sis factor-alpha (TNF-alpha). Various events involving
chemoattractant cytokines release, endothelial-leu-
kocyte adhesion molecules upregulation, recruitment
and migration of leukocytes from systemic compart-
ment to the brain ischaemic zone, and transforma-
tion of endothelium to a prothrombotic state con-
tribute to the development of local inflammation
[1,6,13,20,30,32]. Thus, TNF-alpha may promote
expansion of the brain infarct in a dual way, viz. (1)
intracerebral accumulation of leukocytes plays a cru-
cial role in the development of necrosis [26,35]
whereas retention of leukocytes, which occurs in the
brain microcirculation during reperfusion, decreas-
es microvascular flow [36], (2) downregulation of two
major antithrombotic mechanisms, i.e. tissue plasmi-
nogen activator and thrombomodulin [9,24,45]. Leu-
kocytes, having invaded the brain, in turn, cause
subsequent microvascular occlusion, increased vas-
cular permeability, vasomotor reactivity and release
of oxygen free radicals and cytotoxic enzymes
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[3,7,29,47,52]. Finally, this leads to enlargement of
the ischaemic focus. Therefore, investigations of
stroke-induced inflammmatory phenomena seem to
be very important, because neuronal cell death can
appear in the core of the brain infarcted area if the
blood flow is below 10 ml/100g tissue per minute,
and may extend to the penumbral area even after
reflow [27]. The evolution of TNF-alpha-induced in-
flammmatory events was mainly described in ex-
perimental animal models of brain ischaemia
[17,25,44,48,51]. In humans, elevated leukocyte
counts have been reported to be a risk factor for
cerebral infarction [34]. However, the literature on
white blood cells (WBC) counts in human acute is-
chaemic stroke presents divergent data. Grau et al.
[19] showed no significant increase of blood leuko-
cytes during the first 3 days after the onset of is-
chaemic cerebrovascular event. Silvestrini et al. [37]
observed significantly increased values of WBC
counts within 6 days following ischaemic stroke.
Then, Pozzilli et al. [33] demonstrated the signifi-
cant increase in WBC counts measured on the 3rd
day after the onset of ischaemic stroke in compari-
son with the values during the first 48 hours after
stroke. Nevertheless, Pozzilli et al. [32] emphasised that
the reinjected circulating WBCs of patients with brain
infarct that were labelled in vitro with Indium-111
infiltrated into the infarcted hemisphere as early as
two hours after stroke. We have recently demon-
strated that ischaemic stroke patients displayed in-
creased TNF-alpha levels in cerebrospinal fluid (CSF)
and serum, which correlated with the volume of
evolving brain infarct within the first 24 hours after
the disease onset [50]. The aim of the present study
was to investigate whether WBC counts can be in-
creased in ischaemic stroke patients within the first
24 hours after the appearance of neurological symp-
toms in comparison with control group, and if so, to
evaluate whether elevated WBC counts can be relat-
ed to increased TNF-alpha levels in CSF and serum.
MATERIAL AND METHODS
Patients
Twenty-three patients with first-ever ischaemic stroke
in a lifetime (mean age – SD  72.2 – 10.8 years, 6
men and 17 women) entered the study consecutive-
ly. Patients with concurrent diseases or conditions
interfering with the aim of the study, like haemato-
logical disorders, infections, autoimmune diseases,
identified cardioembolic sources, myocardial infarc-
tions, malignancies, undergoing surgical interven-
tions within the previous 12 months, and those on
immunosuppressive drugs, were excluded. All the
patients presented completed ischaemic stroke, de-
fined as clinical symptoms persisting for more than
24 hours [8]. All the patients with ischaemic stroke
had symptoms confined to the carotid artery terri-
tory. The diagnosis of ischaemic stroke was confirmed
by computerised tomography of the brain performed
immediately after admission. Blood samples were
obtained for the WBC counts within the first 24 hours
after the onset of stroke. CSF, which was obtained
for diagnosis, and serum samples were used for the
analysis of TNF-alpha levels. Fifteen individuals (mean
age – SD  70.1 – 8.6 years, 4 men and 11 wom-
en) with the diagnosis of neurasthenia and tension
headache served as a control group. The study was
performed on the basis of written consent of each
patient and approval of the Ethics Committee of the
University School of Medicine in Poznan.
Laboratory procedures
Blood samples were taken from intravenous cannu-
lae and WBC counts were performed by an auto-
mated haematology analyser. CSF samples for the
estimation of TNF-alpha levels were centrifuged im-
mediately after lumbar puncture and the superna-
tants were stored at 80°C until analysis. Blood sam-
ples destined for the analysis of TNF-alpha levels in
serum were allowed to clot at room temperature for
30 minutes, and after blood centrifugation for 10
minutes, the obtained serum was stored at 80°C.
TNF-alpha levels in CSF and serum samples were
quantified by ELISA method (Quantikine R & D Sys-
tems, Minneapolis, MN, USA) according to the manu-
facturers instruction. The sensitivity of the method
was 4.4 pg/ml.
Statistical analysis
Statistical analysis of WBC counts was performed
using t-Students test for independent variables. Fur-
ther statistical evaluations were based on the as-
sumption that the data were not normally distribut-
ed, and the analysis was performed with nonpara-
metric tests. U Mann-Whitneys test was used to
compare TNF-alpha levels in CSF and serum in stroke
patients with control group. Spearmans rank-order
correlation test was used in the study of the group
of ischaemic stroke patients to calculate the correla-
tion between TNF-alpha levels in CSF and serum and
the values of WBC counts. The results are presented
as mean – SD. P < 0.05 was considered statistically
significant.
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RESULTS
WBC counts in patients within 24 hours of the
onset of stroke
The group of ischaemic stroke patients showed sig-
nificantly higher values of WBC counts compared
with control group (8.1 – 2.4 x 103 cells/µl versus
5.4 – 1.1 x 103 cells/µl; p < 0.001; Fig.1). The high-
est value of WBC counts in the group of ischaemic
stroke patients was 11.8 x 103 cells/µl, with the low-
est being 4.3 x 103 cells/µl. The highest value of WBC
counts in control group was 7.1 x 103 cells/µl, where-
as the lowest was 3.1 x 103 cells/µl.
CSF TNF-alpha levels in patients within 24 hours
of the onset of stroke
The group of ischaemic stroke patients displayed sta-
tistically significant elevated levels of TNF-alpha in
CSF compared with control group (9.1 – 5.8 pg/ml
versus 6.6 – 0.5 pg/ml; p < 0.05; Fig. 2). The high-
est level of TNF-alpha in CSF in the group of ischaemic
stroke patients was 95.0 pg/ml, whereas the lowest
was 5.7 pg/ml. The highest level of CSF TNF-alpha in
control group was 7.6 pg/ml, whereas the lowest
was 5.3 pg/ml.
Serum TNF-alpha levels in patients within 24 hours
of the onset of stroke
The group of ischaemic stroke patients demonstrat-
ed statistically significant increased levels of TNF-al-
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Figure 1. Mean – SD of values of WBC counts [cells ¥ 103/µl]
in both the group of ischaemic stroke patients (Stroke) and con-
trol group (Controls).
pha in serum compared with control group (14.0 –
– 10.2 pg/ml versus 9.1 – 1.6 pg/ml; p < 0.05; Fig. 3).
The highest level of TNF-alpha in serum in the group
of ischaemic stroke patients was 55.0 pg/ml, the low-
est being 6.8 pg/ml. The highest level of TNF-alpha
in serum in control group was 13.0 pg/ml, whereas
the lowest was 6.8 pg/ml.
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Figure 3. Mean – SD of serum TNF-alpha levels [pg/ ml] in both
the group of ischaemic stroke patients (Stroke) and control group
(Controls).
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Figure 2. Mean – SD of CSF TNF-alpha levels [pg/ml] in both the
group of ischaemic stroke patients (Stroke) and control group
(Controls).
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CSF and serum TNF-alpha levels in relation to the
values of WBC counts in patients within 24 hours of
the onset of stroke
No statistically significant correlation was found be-
tween CSF and serum TNF-alpha levels and values of
WBC counts in the group of ischaemic stroke pa-
tients (r = 0.09; p < 1.0 and r = 0.08; p < 1.0,
respectively).
DISCUSSION
The present study demonstrated that ischaemic
stroke patients within the first 24 hours of the dis-
ease onset displayed an increase in WBC counts and
an increase in TNF-alpha levels in CSF and serum.
However, neither increased CSF TNF-alpha levels nor
increased serum TNF-alpha levels correlate with ele-
vated WBC counts.
The elevated CSF TNF-alpha levels observed in this
study may suggest intracerebral TNF-alpha synthe-
sis during the early phase of ischaemic stroke. Many
of the studies of acute cerebral ischaemia performed
in animal models showed expression of TNF-alpha
in ischaemic neurons, microglia, macrophages (es-
pecially in the cells present in ischaemic core and
perifocal zone), astroglia and ependymal cells already
within the first hours following the occlusion of ce-
rebral artery [10,18,40,41,49]. Thus, the increased
TNF-alpha levels in CSF shown in the present study
may be the result of TNF-alpha production in vari-
ous types of brain cells in the cerebral ischaemic
environment and may reflect stroke-induced inflam-
matory reaction in the brain.
It is not clear if stroke can also induce systemic
inflammatory response, because the cellular sourc-
es of systemic TNF-alpha production in acute is-
chaemic stroke are very poorly recognised. TNF-al-
pha is produced mainly by endothelial cells and acti-
vated mononuclear leukocytes, and both TNF-alpha
and sTNFR-1 (soluble TNF receptor protein-1 p55,
being the shedded extracellular portion of the TNF-
-alpha receptor) were found to be elevated in vari-
ous infectious, inflammatory and malignant diseas-
es [2,12]. Elneihoum et al. [14] showed that patients
with acute ischaemic cerebrovascular diseases stud-
ied between 1 and 3 days after the event displayed
higher serum sTNFR-1 (the marker for systemic leu-
kocyte activation) levels than control subjects. Re-
cently, Ferrarese et al. [16] reported high and signif-
icant increase of TNF-alpha release from stimulated
blood leukocytes from day 1 or 2 until day 90 after
stroke. These authors suggest that the ischaemic
process in the central nervous system induces
a long-lasting activation of TNF-alpha production
in peripheral blood cells, which may be a major
source of this cytokine in serum after stroke in hu-
mans. However, the inflammatory events described
by Elneihoum et al. [14] and Ferrarese et al. [16]
may exist already in chronic vascular injury before
acute stroke. Further, TNF-alpha may play a signifi-
cant role in the activation of leukocytes and in the
initiation, formation and progression of arterial
thrombosis [4,5,11,21,22,28,38,39,46]. This suggests
a strong involvement of this cytokine in the develo-
pment of arterial wall pathological changes which
precede and can lead to stroke. Moreover, associa-
tion of the main stroke risk factor, hypertension, with
increased stimulated TNF-alpha release from blood
vessels or cells, seems important [23]. Thus, in our
opinion, the elevated TNF-alpha levels in serum of
ischaemic stroke patients shown in this study may
reflect the existence of systemic proinflammatory
state in acute ischaemic stroke as well as the pre-
sence of stroke-induced systemic inflammatory re-
action. We believe that further studies on the serum
TNF-alpha levels in stroke would require the com-
parison of serum cytokine levels in the group of is-
chaemic stroke patients with the group of non-stroke
patients that present stroke risk factors. This is
planned to be involved in our future studies.
The significantly increased values of WBC counts
in patients within the first 24 hours of the onset of
ischaemic stroke, as observed in this study, are in
accordance with the results obtained by Silvestrini
et al. [37]. Pozzilli et al. [33] reported that WBC counts
determined three days after the onset of ischaemic
stroke correlate with the severity of neurological
impairment and the size of brain infarct. However,
similarly to the question raised regarding the in-
creased levels of TNF-alpha in serum observed in our
study, the problem appears if increased WBC counts
found at early phase of stroke may be stroke-induced.
Indeed, the stress that accompanies an acute is-
chaemic stroke seems to be responsible for adrena-
line release, which leads to the stimulation of leuko-
cyte adrenergic receptors and subsequent leukocy-
tosis [42]. The stroke patients displayed significantly
higher values of plasma oxidation of adrenaline to
adrenochrome, the process that has been shown to
reflect the activation of leukocytes [42]. However,
elevated WBC counts observed at early phase of
stroke are also characteristic of chronic vascular in-
jury, because increased values of WBC counts are
a significant predictor and risk factor for ischaemic
stroke disease [15,34].
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The lack of correlation between increased TNF-
-alpha levels in CSF and serum and elevated WBC
counts within the first 24 hours of ischaemic stroke,
as observed in this study, suggests that TNF-alpha
overexpression is not dependent on increased total
number of peripheral leukocytes.
Increase in CSF TNF-alpha levels may be conside-
red an event which probably reflects the level of
stroke-related acute brain inflammation. Numerous
authors have stressed that the migration of leuko-
cytes into evolving brain infarct occurs in very early
phase of stroke. Garcia et al. [17] reported initiation
of intravascular neutrophil recruitment following
middle cerebral artery occlusion in a rat within 30
minutes of onset of cerebral ischaemia, with its in-
tracerebral levels peaking at 24 hours. Hallenbeck et
al. [20] showed migration of neutrophils into the
brain ischaemic region within 60 minutes of is-
chaemia.
Increase in TNF-alpha levels in serum may reflect
the level of systemic proinflammatory activity, be-
cause the absence of correlation between elevated
serum TNF-alpha levels and increase of total WBC
counts may suggest that not all WBCs synthetise TNF-
-alpha in peripheral circulation. This may also argue
for involvement of not only WBCs but also endothe-
lial cells in systemic TNF-alpha production.
CONCLUSIONS
Data obtained from our study on acute phase of is-
chaemic stroke allow the following conclusions:
 high CSF TNF-alpha levels suggest involvement of
this cytokine in the initiation of stroke-induced
intracerebral inflammation;
 high serum TNF-alpha levels suggest the presence
of systemic proinflammatory state, which contribu-
tes to ischaemic inflammatory cerebrovascular
damage;
 the elevated levels of TNF-alpha in CSF and serum
are not directly linked to increase in WBC counts,
suggesting that different cell types contribute to
the TNF-alpha production during the initial phase
of ischaemic stroke.
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